DGAP-News: STRATEC Biomedical AG / Key word(s): Agreement/Alliance
Marketing agreement between Artel and STRATEC
12.01.2015 / 09:29
---------------------------------------------------------------------
Marketing agreement between Artel and STRATEC
Birkenfeld, January 12, 2015
STRATEC Biomedical AG, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard,
TecDAX) and Artel, Westbrook, Maine, USA, the worldwide leader in
laboratory liquid handling quality assurance, have announced an exclusive
marketing agreement for STRATEC's patented "Tholos" liquid handling quality
assurance instrumentation solution.
Under the agreement, effective as of January 1, 2015, Artel will
exclusively market the "Tholos" technology developed by STRATEC under
Artel's brand name in its core markets.
STRATEC's "Tholos" measures the volume of liquids in reaction wells using
an innovative pressure-based technology that accurately and repeatedly
assesses volume regardless of the size of the reaction well, its shape or
coloring. This makes it possible to record critical process parameters for
sample handling operations in laboratory applications in the pharmaceutical
industry, life science research, production and assay development. The
system can therefore be used as an in-process control for nearly all types
of liquid handling applications.
"Our customers will benefit from this powerful technology, which further
enhances their ability to ensure high-quality results", says Kirby Pilcher,
president of Artel. "The strategic partnership with STRATEC, a leader in
providing automated systems used in laboratories worldwide, has resulted in
a perfect addition to Artel's portfolio of liquid handling quality
assurance products and services".
"The system is an innovative volume control solution that closes a gap in
in-process control for high throughput automation processes", added Marcus
Wolfinger, Chairman, Board of Management of STRATEC. "We are very proud to
have gained Artel, the global market leader in liquid handling quality
assurance, as a partner".
About Artel
Laboratories worldwide depend upon Artel technology and expertise to
standardize and optimize their liquid handling instruments and processes,
and to give them total confidence in their results. Since 1982, Artel has
been solving liquid handling quality, productivity and compliance
challenges in laboratories in pharmaceutical and biotechnology research,
regulatory bodies, academia, clinical diagnostics, forensics, public
health, agbio, food quality and safety and environmental testing.
Artel provides quality assurance systems and a broad and fully customizable
range of support, training and consultation services for laboratories using
automated liquid handling instrumentation and manual pipettes. For more
information visit www.artel-usa.com.
About STRATEC
STRATEC Biomedical AG (www.stratec.com) designs and manufactures fully
automated analyzer systems for its partners in the fields of clinical
diagnostics and biotechnology. These partners market such systems, in
general together with their own reagents, as system solutions to
laboratories, blood banks and research institutes around the world. The
company develops its products on the basis of its own patented
technologies.
Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard
segment of the Frankfurt Stock Exchange and are listed in the TecDAX select
index of the German Stock Exchange.
Further information can be obtained from:
STRATEC Biomedical AG
André Loy, Corporate Communications
Gewerbestr. 37, 75217 Birkenfeld
Germany
Tel: +49 7082 7916-190
Fax: +49 7082 7916-999
ir@stratec.com
www.stratec.com
---------------------------------------------------------------------
12.01.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Phone: +49 (0)7082 7916 0
Fax: +49 (0)7082 7916 999
E-mail: info@stratec.com
Internet: www.stratec.com
ISIN: DE0007289001
WKN: 728900
Indices: TecDAX
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
311907 12.01.2015
DGAP-News: Marketing agreement between Artel and STRATEC
| Source: EQS Group AG